Sinopharm Group Co Ltd banner

Sinopharm Group Co Ltd
HKEX:1099

Watchlist Manager
Sinopharm Group Co Ltd Logo
Sinopharm Group Co Ltd
HKEX:1099
Watchlist
Price: 21.18 HKD 0.57% Market Closed
Market Cap: HK$66.1B

Balance Sheet

Balance Sheet Decomposition
Sinopharm Group Co Ltd

Balance Sheet
Sinopharm Group Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
1 839
1 956
1 712
6 617
7 475
13 091
9 722
14 002
15 232
19 966
25 573
32 241
40 299
39 192
50 178
43 529
55 222
63 809
54 313
Cash
1 839
1 956
1 712
6 617
7 475
13 091
9 722
14 002
15 232
19 966
25 573
32 241
40 299
39 192
50 178
43 529
55 222
63 809
54 313
Short-Term Investments
0
0
0
0
3
10
2
1
1
2
5
1
41
0
39
12
106
5
2 552
Total Receivables
5 067
6 377
8 043
13 565
18 044
27 379
37 957
52 669
67 071
66 595
72 781
84 914
110 364
126 563
149 448
176 273
175 787
189 855
206 768
Accounts Receivables
4 552
5 581
7 254
9 608
16 190
24 123
34 168
46 900
61 825
58 346
59 759
68 557
96 610
109 497
134 404
159 409
153 283
165 966
183 069
Other Receivables
515
796
789
3 957
1 854
3 256
3 789
5 769
5 246
8 249
13 022
16 357
13 754
17 066
15 044
16 864
22 505
23 889
23 699
Inventory
2 307
2 904
3 559
4 632
8 460
13 882
15 956
18 825
20 309
22 553
25 760
30 273
35 389
42 594
47 085
51 500
60 926
60 028
62 353
Other Current Assets
184
719
368
474
881
1 870
2 380
4 217
7 660
8 784
8 641
15 343
18 562
21 650
20 859
19 608
27 366
23 139
21 461
Total Current Assets
9 398
11 955
13 681
25 287
34 863
56 233
66 016
89 713
110 272
117 900
132 760
162 771
204 655
230 000
267 610
290 922
319 406
336 835
347 448
PP&E Net
1 088
1 193
1 257
1 448
3 331
4 431
5 382
6 311
7 102
7 642
6 752
9 008
11 025
18 063
18 896
19 408
19 647
19 898
19 632
PP&E Gross
1 088
1 193
1 257
1 448
3 331
4 431
5 382
6 311
7 102
7 642
6 752
9 008
11 025
18 063
18 896
19 408
19 647
19 898
19 632
Accumulated Depreciation
421
473
508
594
925
1 249
1 584
2 118
2 600
3 243
3 130
4 206
5 183
6 205
7 404
8 833
14 845
16 457
18 435
Intangible Assets
150
145
116
201
822
1 650
2 153
2 137
2 624
2 723
2 448
2 554
2 577
3 325
3 442
3 193
3 015
3 010
2 697
Goodwill
26
26
31
124
688
2 879
3 397
3 466
3 724
4 000
3 835
4 699
4 899
5 664
7 287
7 199
7 156
7 186
6 252
Note Receivable
0
0
0
0
0
0
0
0
0
1 550
3 788
14
10
18
34
12
6
684
1 102
Long-Term Investments
330
394
421
482
692
883
1 070
1 165
1 640
1 850
4 200
6 911
7 649
8 520
9 107
9 773
10 379
11 052
11 287
Other Long-Term Assets
599
574
608
734
1 619
1 552
1 829
2 661
3 293
3 765
3 928
4 735
4 956
4 299
4 861
4 906
5 166
4 730
4 413
Other Assets
26
26
31
124
688
2 879
3 397
3 466
3 724
4 000
3 835
4 699
4 899
5 664
7 287
7 199
7 156
7 186
6 252
Total Assets
11 590
N/A
14 287
+23%
16 115
+13%
28 275
+75%
42 014
+49%
67 628
+61%
79 847
+18%
105 453
+32%
128 656
+22%
139 430
+8%
157 712
+13%
190 693
+21%
235 771
+24%
269 888
+14%
311 237
+15%
335 412
+8%
364 775
+9%
383 395
+5%
392 831
+2%
Liabilities
Accounts Payable
5 630
7 210
9 053
12 135
19 831
27 054
34 685
44 188
54 724
59 563
66 746
72 492
83 683
100 334
112 632
128 431
137 085
146 632
151 109
Accrued Liabilities
426
451
427
461
599
934
1 134
1 582
1 692
2 130
2 654
4 057
4 476
5 404
7 760
8 354
9 571
8 832
8 123
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1 892
Current Portion of Long-Term Debt
1 704
1 522
1 504
1 284
3 344
8 667
10 888
21 007
25 233
28 355
22 363
31 649
50 085
43 669
56 365
56 700
54 633
56 527
62 597
Other Current Liabilities
509
1 764
894
874
1 980
3 637
3 398
4 064
4 372
5 573
7 975
16 386
21 830
29 017
27 220
25 821
33 673
29 499
26 654
Total Current Liabilities
8 270
10 947
11 878
14 755
25 754
40 292
50 105
70 841
86 020
95 622
99 737
124 583
160 074
178 425
203 977
219 307
234 963
241 491
250 376
Long-Term Debt
178
158
130
50
91
5 182
5 192
4 134
4 223
758
11 205
5 594
5 019
11 470
12 162
11 669
14 957
17 255
11 897
Deferred Income Tax
70
67
64
97
266
518
592
596
633
693
601
847
865
1 099
1 112
1 023
937
788
639
Minority Interest
831
935
1 146
1 594
3 008
4 714
5 665
6 796
8 908
10 768
12 722
19 646
25 454
29 517
33 588
37 768
42 001
45 737
47 804
Other Liabilities
483
498
633
869
1 185
1 248
1 215
1 270
1 491
1 478
1 636
1 722
1 537
1 955
4 039
3 760
3 849
3 542
3 233
Total Liabilities
9 831
N/A
12 604
+28%
13 851
+10%
17 364
+25%
30 303
+75%
51 954
+71%
62 769
+21%
83 638
+33%
101 274
+21%
109 319
+8%
125 901
+15%
152 392
+21%
192 949
+27%
222 466
+15%
254 878
+15%
273 526
+7%
296 707
+8%
308 813
+4%
313 947
+2%
Equity
Common Stock
1 637
1 637
1 637
2 265
2 265
2 403
2 403
2 568
2 767
2 767
2 767
2 767
2 972
2 972
3 121
3 121
3 121
3 121
3 121
Retained Earnings
129
46
631
8 642
9 642
13 492
3 840
5 350
6 521
9 232
10 936
17 441
18 615
23 212
28 574
34 107
40 293
46 803
51 107
Additional Paid In Capital
11
11
11
12
212
230
10 826
13 885
18 077
18 077
18 077
18 077
21 223
21 223
24 641
24 641
24 641
24 641
24 641
Unrealized Security Profit/Loss
5
12
7
16
16
10
10
12
17
34
31
17
12
16
23
20
17
21
19
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
4
Total Equity
1 760
N/A
1 684
-4%
2 264
+34%
10 911
+382%
11 711
+7%
15 674
+34%
17 078
+9%
21 816
+28%
27 382
+26%
30 110
+10%
31 811
+6%
38 301
+20%
42 822
+12%
47 422
+11%
56 359
+19%
61 886
+10%
68 069
+10%
74 582
+10%
78 884
+6%
Total Liabilities & Equity
11 590
N/A
14 287
+23%
16 115
+13%
28 275
+75%
42 014
+49%
67 628
+61%
79 847
+18%
105 453
+32%
128 656
+22%
139 430
+8%
157 712
+13%
190 693
+21%
235 771
+24%
269 888
+14%
311 237
+15%
335 412
+8%
364 775
+9%
383 395
+5%
392 831
+2%
Shares Outstanding
Common Shares Outstanding
1 637
1 637
1 637
2 265
2 265
2 403
2 403
2 568
2 767
2 767
2 767
2 767
2 972
2 972
3 121
3 121
3 121
3 121
3 121
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett